Moderna, Inc. (MRNA)
NASDAQ: MRNA · IEX Real-Time Price · USD
117.07
+1.12 (0.97%)
At close: Jul 2, 2024, 4:00 PM
116.89
-0.18 (-0.16%)
After-hours: Jul 2, 2024, 7:55 PM EDT
Moderna Market Cap
Moderna has a market cap or net worth of $44.87 billion as of July 2, 2024. Its market cap has decreased by -0.68% in one year.
Market Cap
44.87B
Enterprise Value
37.55B
1-Year Change
-0.68%
Ranking
Category
Stock Price
$117.07
Market Cap Chart
Since December 7, 2018, Moderna's market cap has increased from $6.03B to $44.87B, an increase of 643.55%. That is a compound annual growth rate of 43.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 44.44B | 17.19% |
| Dec 29, 2023 | 37.92B | -45.05% |
| Dec 30, 2022 | 69.01B | -32.99% |
| Dec 31, 2021 | 102.98B | 149.10% |
| Dec 31, 2020 | 41.34B | 534.20% |
| Dec 31, 2019 | 6.52B | 31.58% |
| Dec 31, 2018 | 4.95B | -17.90% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Becton, Dickinson and Company | 66.26B |
| Edwards Lifesciences | 54.38B |
| Humana | 45.01B |
| DexCom | 44.61B |
| Cencora | 44.58B |
| Alcon | 43.44B |
| Takeda Pharmaceutical | 40.79B |
| IDEXX Laboratories | 39.34B |